Sign up to save your podcasts
Or
Share #30. Novel orally active somatostatin analogs for the treatment of acromegaly
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
#30. Novel orally active somatostatin analogs for the treatment of acromegaly
Dr Stephen Betz of Crinetics Pharmaceuticals talks with NEN at ICN 2018 Toronto about his research on the development of treatments for acromegaly; a condition where a pituitary adenoma causes growth hormone hypersecretion causing gigantism in children and abnormal growths in adults.
Interview by Dr. Julie Ann Lough
View all episodes
By NeuroEndoNow.orgDr Stephen Betz of Crinetics Pharmaceuticals talks with NEN at ICN 2018 Toronto about his research on the development of treatments for acromegaly; a condition where a pituitary adenoma causes growth hormone hypersecretion causing gigantism in children and abnormal growths in adults.
Interview by Dr. Julie Ann Lough